Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
52.1K
-
Shares change
-
-9.73M
-
Total reported value, excl. options
-
$7.13K
-
Value change
-
-$1.36M
-
Number of buys
-
1
-
Number of sells
-
-34
-
Price
-
$0.14
Significant Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q2 2024
36 filings reported holding GRTX - Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q2 2024.
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.1K shares
of 75.5M outstanding shares and own 0.07% of the company stock.
Largest 10 shareholders include XTX Topco Ltd (52.1K shares), Bank of New York Mellon Corp (0 shares), LEVEL FOUR ADVISORY SERVICES, LLC (0 shares), LPL Financial LLC (0 shares), Parallel Advisors, LLC (0 shares), J.W. COLE ADVISORS, INC. (0 shares), US BANCORP \DE\ (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), abrdn plc (0 shares), and Good Life Advisors, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.